Endourage Is Conducting Clinical Trials On The Efficacy Of Its Proprietary CBD Formulations

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

CBD is fast becoming a staple in the wellness industry, with extensive clinical research being conducted on its potential medicinal and therapeutic benefits.

Wellness brands such as Endourage have formulated a line-up of CBD-infused products with the mission of enhancing your well-being. 

The company is lead by a team of executives with extensive startup and cannabis experience as well as over two decades of treatment development experience. 

Endourage manufactures only the highest quality premium CBD products to help the people who need it most. The company is working exclusively with hemp and is doing Phase IV human clinical trials to prove the efficacy of its proprietary formulations. 

CEO of Endourage Isaac Foster will be speaking at the upcoming Benzinga Cannabis Capital Conference.

Foster was a healthcare and tech investment banker in the mid to late nineties and over the last 22 years has been a C-suite executive in 10 startups.

In his presentation, Foster will be providing a more in-depth overview of the company as well as discuss various investment opportunities. Endourage’s primary focus is on the $1 trillion clinicians directed use of the cannabinoid formulations market. 

Said Foster, “While there has been a great rush to provide consumers with CBD products, the far greater market will be providing clinicians formulations with proven efficacy for specific indications.”

To learn more about Endourage, you can sign up for the Benzinga Cannabis Capital Conference by clicking here.

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.